3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Ovarian Neoplasms
11
Fallopian Tube Neoplasms
8
Sarcoma
3
Sarcoma, Ewing
2
Neoplasms
2
Neoplasm Metastasis
2
Multi-centric Castleman's Disease
2
Breast Neoplasms
2
Sarcoma, Synovial
1
Sarcoma, Kaposi
1
Rhabdomyosarcoma
1
Recurrent Platinum-Sensitive Fallopian Tube Endometrioid Adenocarcinoma
1
Recurrent Epithelial Ovarian, Fallopian or Peritoneal Carcinoma
1
Peritoneal Neoplasms
1
Parkinson Disease 4, Autosomal Dominant Lewy Body
1
Ovarian Cancer Recurrent
1
Osteosarcoma
1
Macular dystrophy, corneal type 1
1
Lymphoproliferative Disorders
1
Lymphadenopathy
1
Liposarcoma
1
Leiomyosarcoma
1
Hodgkin Disease
1
Histiocytoma, Malignant Fibrous
1
HIV Infections
1
Gliosarcoma
1
Glioblastoma
1
Fallopian Tube Mucinous Adenocarcinoma
1
Dermatofibrosarcoma
1
Acquired Immunodeficiency Syndrome
1
Interventions
Injections
5
pembrolizumab
2
Pemetrexed
2
Carboplatin
2
tislelizumab
1
sotorasib
1
sacituzumab govitecan
1
fludarabine
1
WW Domain-Containing Oxidoreductase
1
SYS6006 COVID-19 vaccine
1
Panitumumab
1
Paclitaxel
1
Oxaliplatin
1
Leucovorin
1
Fluorouracil
1
Drug Therapy
1
Cetuximab
1
Antiemetics
1
4-amino-5-fluoro-3-(5-(4-methylpiperazin-1-yl)-1H-benzimidazol-2-yl)quinolin-2(1H)-one
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Advanced Solid Tumors
×
liposomal doxorubicin
×
30 days
×
Clear all
No trials found.